Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,380.00
+30.00 (1.28%)
At close: Sep 11, 2026

Dx & Vx Revenue

Dx & Vx had revenue of 6.40B KRW in the quarter ending June 30, 2026, a decrease of -26.08%. This brings the company's revenue in the last twelve months to 26.22B, down -15.72% year-over-year. In the year 2025, Dx & Vx had annual revenue of 29.36B, down -13.52%.

Revenue (ttm)
26.22B
Revenue Growth
-15.72%
P/S Ratio
8.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
234.26B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202529.36B-4.59B-13.52%
Dec 31, 202433.95B-7.30B-17.69%
Dec 31, 202341.24B9.06B28.15%
Dec 31, 202232.18B24.71B330.83%
Dec 31, 20217.47B-226.13M-2.94%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GC Medical Science102.16B
Seoulin Bioscience83.17B
Cytogen27.38B
Protia17.75B
HLB Panagene14.71B
3billion11.71B
GENINUS11.28B
Median Diagnostics7.86B
Revenue Rankings